RFA
EDIT icon

Reilly Financial Advisors’s Editas Medicine EDIT Stock Holding History

Reilly Financial Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$7K Buy
+250
New +$8.61K ﹤0.01% 778

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Reilly Financial Advisors's EDIT Position: Q4 2021 in Review

Reilly Financial Advisors opened a new position in Editas Medicine (EDIT) in Q4 2021: 250 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #778 among its holdings.

306 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • Reilly Financial Advisors held 250 shares of Editas Medicine worth $7K as of Q4 2021.
  • Editas Medicine was a new Reilly Financial Advisors position in Q4 2021.
  • Editas Medicine made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #778 holding.
  • 306 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.